Demyelinating Diseases

Search with Google Search with Bing
Information
Disease name
Demyelinating Diseases
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03562975 Active, not recruiting Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus July 23, 2018 December 2023
NCT04837651 Completed Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab March 2, 2021 July 1, 2021
NCT00283023 Completed Phase 1 Oligodendrocyte Progenitor Cell Culture From Human Brain December 2007 December 2010
NCT01056471 Completed Phase 1/Phase 2 Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis January 2010 June 2015
NCT00001287 Completed Phase 2 Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) December 1990 January 2001
NCT03268239 Completed N/A Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions August 2, 2017 April 26, 2021
NCT06065670 Not yet recruiting Phase 1/Phase 2 Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy March 1, 2024 October 30, 2026
NCT05605951 Recruiting Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve August 15, 2020 December 31, 2025
NCT04539002 Recruiting Phase 1/Phase 2 Aerobic Exercise for Remyelination in Multiple Sclerosis April 29, 2021 March 9, 2026
NCT05792176 Recruiting N/A Ukulele Playing to Improve Cognition in People With Multiple Sclerosis: A Feasibility Study March 27, 2023 August 1, 2025
NCT05834855 Recruiting Phase 3 Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS April 2023 May 2027
NCT04762342 Recruiting N/A Power Training in Older Multiple Sclerosis Patients December 7, 2020 August 28, 2024
NCT01963650 Terminated Natural History Study of Children With Metachromatic Leukodystrophy November 2, 2015 April 8, 2016
NCT05199363 Unknown status N/A Pediatric Patient Experience on a Diagnostic Path October 15, 2021 December 15, 2022
MeSH unique ID (MeSH (Medical Subject Headings))
D003711